Latest Regulatory News

Thorney Technologies Limited (ASX, TEK) will resume trading on the ASX from 16 December 2025 following the lodgement of its Net Tangible Asset Backing, ending its recent suspension.

ECS Botanics is strategically preparing for entry into the US medicinal cannabis market, leveraging its EU-GMP certification and proprietary genetics amid evolving regulatory landscapes.

Bank of Queensland Limited has announced a fully franked quarterly distribution of AUD 1.2412 per Capital Note 3 security, payable in March 2026. The distribution reflects a 4.9784% annualised rate based on the BBSW plus a margin.

Theta Gold Mines has entered a non-binding agreement for an $80 million USD senior secured loan to fully fund its TGME Gold Mine Project, aiming for first gold pour in early 2027. The deal includes flexible funding tranches and equity-linked warrants.

American Rare Earths has successfully produced mixed rare earth oxides from Halleck Creek ore, marking a pivotal technical breakthrough in its mineral processing program. This achievement advances the project closer to commercial viability amid growing demand for critical minerals.

Emyria has secured its first Empax clinic in Victoria, marking a significant step in its multi-state expansion and validating its scalable, reimbursed national mental health platform.

Centrepoint Alliance forecasts a robust 13% increase in EBITDA for the first half of FY26, driven by strong adviser recruitment and platform scaling, cementing its position as the second-largest licensee in Australia.

Fiducian Group’s subsidiary Fiducian Investment Management Services Limited has filed a defence after ASIC initiated civil proceedings alleging misleading disclosure and compliance failures related to a managed fund.

Sunrise Energy Metals has raised A$32.5 million through a follow-on placement, advancing its flagship Syerston Scandium Project toward mid-2026 construction. This latest capital injection builds on a total of A$105 million raised since June 2025, underscoring strong investor confidence amid growing scandium demand.

Entropy Neurodynamics has successfully completed dosing the first patient in its TRP-8803 clinical trial for Binge Eating Disorder, marking a key milestone with controlled psychedelic infusion and safety clearance. Top-line results are expected in early 2026.

Immutep Limited reports robust progress in its pivotal Phase III TACTI-004 trial for advanced non-small cell lung cancer, with over 120 clinical sites activated across 27 countries including the US. Patient enrolment has reached 38% of the target, keeping key milestones on track.

MetalsGrove Mining Limited has been granted the Vavoua gold exploration permit in Côte d’Ivoire, advancing its strategic foothold near the Abujar gold mine. An initial soil sampling program using cutting-edge PortablePPB technology is set to commence early next year.